Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
India · Delayed Price · Currency is INR 65.00
-0.95 (-1.44%)
At close: Oct 1, 2026
NSE:AAKAAR Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 66.38 | 60.33 | 28.7 | 21.53 | 18 |
Depreciation & Amortization | 1.28 | 1.25 | 1.35 | 0.89 | 0.22 |
Asset Writedown & Restructuring Costs | - | - | - | 0.14 | - |
Stock-Based Compensation | - | 0.16 | 0.11 | 0.05 | - |
Other Operating Activities | 14.68 | 15.37 | 6.7 | 6.34 | -0.12 |
Change in Accounts Receivable | -95.25 | -117.74 | -61.06 | -50.32 | 10.57 |
Change in Inventory | -51.96 | -3.75 | -29.26 | -42.55 | -7.11 |
Change in Accounts Payable | -16.12 | 18.48 | -5.76 | 9.09 | -2.46 |
Change in Other Net Operating Assets | -2.62 | -28.15 | -21.22 | 25.54 | -16.1 |
Operating Cash Flow | -83.61 | -54.06 | -80.44 | -29.28 | 2.99 |
Operating Cash Flow Growth | - | - | - | - | -93.07% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -5.78 | -0.84 | -0.52 | -2.64 | -1.88 |
Investment in Securities | 0.49 | 0.25 | -0.09 | -0.61 | -0.54 |
Other Investing Activities | 5.78 | 0.05 | 0.22 | 0.04 | 0.16 |
Investing Cash Flow | 0.49 | -0.54 | -0.38 | -3.2 | -2.26 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 102.28 | 91.82 | 29.85 | - |
Total Debt Issued | - | 102.28 | 91.82 | 29.85 | - |
Short-Term Debt Repaid | -42.04 | -25.46 | - | -9.3 | - |
Long-Term Debt Repaid | - | - | - | - | -0.65 |
Total Debt Repaid | -42.04 | -25.46 | - | -9.3 | -0.65 |
Net Debt Issued (Repaid) | -42.04 | 76.82 | 91.82 | 20.55 | -0.65 |
Issuance of Common Stock | 270.03 | 52.57 | - | - | - |
Common Dividends Paid | - | - | - | -5.25 | -5.6 |
Other Financing Activities | -40.03 | -22.28 | -9.91 | -3.61 | - |
Financing Cash Flow | 187.96 | 107.1 | 81.91 | 11.69 | -6.25 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | 0 |
Net Cash Flow | 104.84 | 52.5 | 1.09 | -20.79 | -5.52 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -89.4 | -54.9 | -80.96 | -31.91 | 1.11 |
Free Cash Flow Growth | - | - | - | - | -97.43% |
Free Cash Flow Margin | -13.35% | -8.91% | -17.56% | -9.73% | 0.57% |
Free Cash Flow Per Share | -6.73 | -5.57 | -8.86 | -3.50 | 0.12 |
Levered Free Cash Flow | -110.67 | -70.21 | -93.6 | -34.3 | -2.33 |
Unlevered Free Cash Flow | -100.33 | -60.35 | -87.41 | -32.04 | -2.15 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 16.55 | 15.77 | 9.91 | 3.61 | - |
Cash Income Tax Paid | 22.5 | 19.88 | 12.6 | 10.38 | 6.47 |
Change in Working Capital | -165.95 | -131.16 | -117.3 | -58.24 | -15.11 |